Ignite Creation Date:
2024-05-06 @ 6:43 PM
Last Modification Date:
2024-10-26 @ 2:53 PM
Study NCT ID:
NCT05765825
Status:
RECRUITING
Last Update Posted:
2024-06-20
First Post:
2023-03-01
Brief Title:
Study of Low-Dose Radiotherapy Concurrent Chemotherapy With Serplulimab for Patients With ES-SCLC
Sponsor:
Sichuan University
Organization:
Sichuan University
Organization Data
Organization:
Sichuan University
Class:
OTHER
Study ID:
SPUR
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Sichuan University
Lead Sponsor Class:
OTHER
Responsible Party:
You Lu
Responsible Party Title:
professor
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Sichuan University
Old Name:
None
Old Organization:
None